April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.
New research suggests a high prevalence of hepatitis D, the most severe form of viral hepatitis, in PLWH in regions of Europe, and a particularly high risk for people who inject drugs.
The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.
Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.
Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.
Self-Swabbing Is an Affirming and Effective Cervical-Cancer Screening Tool for Transmasculine People
Transmasculine people face an array of barriers when understanding their HPV risk and accessing cervical-cancer screenings.
Dec. 3, 2020: A simple scoring system for PrEP referral; integrating meth use and HIV prevention interventions; genetically linked HIV strains cross county lines; viral suppression rates in first vs. second pregnancies.
A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.
W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.
Sex is a vital part of human life—and clinicians should be asking about it.